Manelimab (Anti-B7-H1 / PD-L1 / CD274)
Manelimab (Anti-B7-H1 / PD-L1 / CD274) is a monoclonal antibody directed against the immunosuppressive ligand programmed cell death-1 ligand 1 (PD-L1; cluster of differentiation 274; CD274), with potential immune checkpoint inhibitory and antineoplastic activities. MW: 143.68 kD.
Trivial name | BCD-135 |
Catalog Number | A2780 |
CAS# | 2168561-26-8 |
Size | 1mg |